The Top 10 Blockbusters Expected to be Launched by 2019

Who will be the next Prozac or Viagra? In the latest white paper from DRG, our experts predict the top 10 blockbuster drugs expected to be launched by 2019. Here’s a hint… oncology and central nervous system therapies are expected to lead the industry. Find out if your brand made the Top 10.

Questions answered in this white paper include:

  • Will the shift toward targeted therapies lead to a decrease in the number of blockbusters?
  • Are the types of blockbusters expected to change over time?
  • What role will rare diseases play in bringing in revenue?
  • Will the blockbuster model be able to sustain growth for pharmaceutical companies?

How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now